BDNF and psychiatric disorder: In this review, we focus on two promising biomarker candidates that may offer a valid biosignature for a better diagnosis and predict occurrence of psychiatric disorders: neurosteroid biosynthesis, such as allopregnanolone and GABAergic congeners, and expression of neurotrophic proteins, including brain-derived neurotrophic factor (BDNF).